Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 14 | -585K | 100% | $49.62 | -$29M |
Net | -14 | -585K | -100% | -$29M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Brett P. Monia | Chief Executive Officer, Director | $39.7M | -$7.82M | -16.5% | Aug 30, 2024 |
Hougen Elizabeth L | EVP, Finance & CFO | $10.5M | -$650K | -5.82% | Feb 2, 2024 |
Onaiza Cadoret-Manier | EVP,Chf GL Pdt Str & Oper Ofc | $7.95M | -$493K | -5.84% | Feb 2, 2024 |
Richard S. Geary | EVP, Chief Development Officer | $7.78M | -$1.77M | -18.5% | Aug 30, 2024 |
Joseph H. Wender | Director | $6.84M | Jul 15, 2024 | ||
Eugene Schneider | EVP, Chf Clinical Develop Ofcr | $6.83M | -$2.2M | -24.4% | Feb 2, 2024 |
Patrick R. O'neil | EVP CLO & General Counsel | $6.43M | -$1.99M | -23.7% | Aug 30, 2024 |
C. Frank Bennett | EVP, Chief Scientific Officer | $6.34M | -$2.97M | -31.9% | Aug 30, 2024 |
Spencer R. Berthelsen | Director | $6.29M | -$645K | -9.3% | Jul 15, 2024 |
Eric Swayze | EVP Research | $5.87M | -$2.43M | -29.3% | Aug 30, 2024 |
Brian Birchler | EVP, Corp and Development Ops | $4.88M | -$264K | -5.14% | Aug 30, 2024 |
B. Lynne Parshall | Director | $4.57M | -$6.39M | -58.3% | Jul 15, 2024 |
Joseph Baroldi | EVP, Chief Business Officer | $4.57M | -$269K | -5.56% | Apr 15, 2024 |
Frederick T. Muto | Director | $3.44M | Jul 15, 2022 | ||
Joseph Loscalzo | Director | $2.49M | Jul 15, 2024 | ||
Joan E. Herman | Director | $2.31M | Jul 15, 2024 | ||
Michael R. Hayden | Director | $1.98M | Jul 1, 2024 | ||
Peter N. Reikes | Director | $1.25M | Oct 15, 2021 | ||
Joseph Klein III | Director | $1.18M | -$1.05M | -47.1% | Jul 16, 2024 |
Allene M. Diaz | Director | $953K | -$81K | -7.84% | Jul 15, 2024 |
Michael J. Yang | Director | $398K | Jul 1, 2024 | ||
Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | $68.5K | Feb 26, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|